Tag: prescription opiates
Workforce drug positivity at highest rate in a decade
Driven by increases in cocaine, methamphetamine, and marijuana, drug use by the American workforce remains at its highest rate in more than a decade.
Clarifying the changes in federal workplace drug testing & documentation
Changes to the federal drug testing panel and paperwork are forthcoming, but for now you should continue testing as usual.
Revisions to Federal workplace drug testing
HHS revised its mandatory guidelines to expand federal urine drug testing to include hydrocodone, hydromorphone, oxycodone, and oxymorphone.
CDC proposes limitation on prescription opiates
The CDC has proposed new prescribing guidelines for doctors, urging them to try other pain relief methods before opting for opioids.
2015 National Prescription Drug Take-Back Day
The DEA has announced its tenth annual National Prescription Drug Take-Back Day, an event to help people dispose any unused prescription medications.
The prescription drug misuse epidemic
While data from the DTI revealed recent positivity rate declines for prescription opiates, the increased misuse continues to be a growing concern.
Ask the experts: Marijuana legalization and workplace drug testing
Marijuana impairs users when driving or completing other complex tasks even hours after use - making it vital for employers to continue to screen for marijuana.
Dissecting the data
Dr. Barry Sample, Quest Diagnostics, pours through the numbers in his DATIA Focus article “Assessing Drug Use Trends in the United States.”
Webinar insights: Tracking the trends
Dr. Barry Sample, Director of Science and Technology, reviewed key data and insights from the Quest Diagnostics Drug Testing Index.
Drug Testing Index: A look at 2008 – 2013
The Quest Diagnostics Drug Testing Index reveals insights into patterns of drug use among the American workforce. As we celebrate our 30th anniversary, we take a deeper look at overall positivity rates and key milestones from 2008 to 2013.